Literature DB >> 1546712

Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.

C Shimazaki1, H Gotoh, E Ashihara, N Oku, T Inaba, S Murakami, K Itoh, Y Ura, M Nakagawa, N Fujita.   

Abstract

To clarify the biological characteristics of the myeloma cells in primary plasma cell leukemia (PCL), we studied the immunological phenotype and DNA content of cells from five patients with primary PCL as compared to those from the patients with typical multiple myeloma (MM). In two of five patients with PCL myeloma cells had B-cell-associated antigens (B1, J5) and surface immunoglobulin in addition to plasma cell associated antigens, suggesting that these cells are immunologically immature as compared to mature plasma cells. Concerning the DNA content of myeloma cells, two of four patients had hypodiploid while two had diploid myeloma cells. In contrast, 24 of the 37 (65%) patients with typical MM had hyperdiploid and 1 had hypodiploid myeloma cells. These observations suggest that the myeloma cells in PCL are immunologically heterogeneous. The increased incidence of hypodiploidy in PCL may explain its relatively poor prognosis as previously shown in those with typical MM and hypodiploid DNA content.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546712     DOI: 10.1002/ajh.2830390302

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.

Authors:  D Tabernero; J F San Miguel; M Garcia-Sanz; L Nájera; M García-Isidoro; J A Peréz-Simon; M Gonzalez; J Wiegant; A K Raap; A Orfão
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

2.  Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.

Authors:  Giampaolo Talamo; Nathan G Dolloff; Kamal Sharma; Junjia Zhu; Jozef Malysz
Journal:  Rare Tumors       Date:  2012-08-14

3.  Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.

Authors:  H Goto; C Shimazaki; T Tatsumi; N Yamagata; T Hirata; E Ashihara; N Oku; T Inaba; N Fujita; Y Koishihara
Journal:  Jpn J Cancer Res       Date:  1994-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.